Literature DB >> 7591410

Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects.

A Barral1, J M Costa, A L Bittencourt, M Barral-Netto, E M Carvalho.   

Abstract

BACKGROUND: Diffuse cutaneous leishmaniasis (DCL) is a rare manifestation of human leishmaniasis, characterized by multiple, slowly progressive nodules or plaques without ulceration, involving almost the entire body. It has been suggested, that DCL results from a lack of cell-mediated immunity to leishmanial antigen, leading to uncontrolled parasite growth.
METHODS: We have performed detailed clinical, histopathologic, and immunologic investigations in six patients with DCL. Biopsies were taken from the nodules, processed, and examined for determination of the macrophagic pattern present, based on the intensity of vacuolation and the frequency of vacuolated cells, the parasite index, and the presence of eosinophils. Immunologically, patients were evaluated by their response to intradermal skin test to PPD or leishmania antigen, determination of antileishmania antibodies by immunofluorescent assay, and lymphocyte proliferation assay.
RESULTS: There seemed to be a negative relation between nodules and skin ulcerations, whereas the highest number of parasites were observed in patients with the greatest number of vacuolated macrophages. The delayed hypersensitivity skin test to leishmanial antigen was negative, and antileishmania IgG antibodies were positive in all patients.
CONCLUSIONS: Although all cases fulfill the criteria for being classified as DCL, they present a wide spectrum. Three cases were clearly at the unresponsive pole, and three other cases belonged to the subpolar form of DCL, exhibiting varying weak signs of antiparasite responsiveness.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7591410     DOI: 10.1111/j.1365-4362.1995.tb00613.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  23 in total

1.  Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response.

Authors:  Paulo R Machado; Maria Elisa A Rosa; Diego Costa; Moema Mignac; João S Silva; Albert Schriefer; Mauro M Teixeira; Olivia Bacellar; Edgar M Carvalho
Journal:  Trans R Soc Trop Med Hyg       Date:  2011-07-02       Impact factor: 2.184

2.  Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Augusto M Carvalho; Luiz H Guimarães; Rúbia Costa; Maíra G Saldanha; Iana Prates; Lucas P Carvalho; Sérgio Arruda; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

3.  Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.

Authors:  Cláudia Maria Castro Gomes; Maria Gloria Teixeira Sousa; Joyce Prieto Bezerra Menezes; Marliane Campos Batista; Ana Carolina Stocco Lima; Walter Belda; Daniel Bradshaw; Monica Elinor Alves Gama; Márcia Dalastra Laurenti; Fernando Tobias Silveira; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2017-02-21       Impact factor: 2.289

Review 4.  CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.

Authors:  Fernanda O Novais; Phillip Scott
Journal:  Semin Immunopathol       Date:  2015-03-24       Impact factor: 9.623

5.  Oligopeptidase B from Leishmania amazonensis: molecular cloning, gene expression analysis and molecular model.

Authors:  Herbert Leonel de Matos Guedes; Monique Pacheco Duarte Carneiro; Daniel Cláudio de Oliveira Gomes; Bartira Rossi-Bergmann; Salvatore Giovanni De-Simone
Journal:  Parasitol Res       Date:  2007-09       Impact factor: 2.289

6.  Transforming growth factor-beta in human cutaneous leishmaniasis.

Authors:  A Barral; M Teixeira; P Reis; V Vinhas; J Costa; H Lessa; A L Bittencourt; S Reed; E M Carvalho; M Barral-Netto
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

7.  Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil.

Authors:  Alon Unger; Seth O'Neal; Paulo R L Machado; Luiz H Guimarães; Daniel J Morgan; Albert Schriefer; Olívia Bacellar; Marshall J Glesby; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

8.  Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.

Authors:  L H Guimarães; P R L Machado; E L Lago; D J Morgan; A Schriefer; O Bacellar; E M Carvalho
Journal:  Trans R Soc Trop Med Hyg       Date:  2009-05-28       Impact factor: 2.184

9.  The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.

Authors:  Alexsandro Souza do Lago; Maurício Nascimento; Augusto M Carvalho; Neuza Lago; Juliana Silva; José Roberto Queiroz; Lucas P Carvalho; Albert Schriefer; Mary Wilson; Paulo Machado; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

10.  Oligopeptidase B from L. amazonensis: molecular cloning, gene expression analysis and molecular model.

Authors:  Herbert Leonel de Matos Guedes; Monique Pacheco Duarte Carneiro; Daniel Cláudio de Oliveira Gomes; Bartira Rossi-Bergmanmn; Salvatore Giovanni de Simone
Journal:  Parasitol Res       Date:  2007-05-27       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.